Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125978481 | 12597848 | 1 | I | 201605 | 20160705 | 20160727 | 20160727 | PER | US-ASTRAZENECA-2016SE73782 | ASTRAZENECA | 835.00 | MON | F | Y | 97.10000 | KG | 20160727 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125978481 | 12597848 | 1 | PS | BYDUREON | EXENATIDE | 1 | Subcutaneous | 22200 | 2 | MG | /wk | ||||||||
| 125978481 | 12597848 | 2 | SS | METOPROLOL SUCCINATE. | METOPROLOL SUCCINATE | 1 | Oral | 0 | 25 | MG | MODIFIED-RELEASE TABLET | QD | |||||||
| 125978481 | 12597848 | 3 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | Oral | 0 | 30 | MG | QD | ||||||||
| 125978481 | 12597848 | 4 | C | NATEGLINIDE. | NATEGLINIDE | 1 | Oral | 0 | 180 | MG | QD | ||||||||
| 125978481 | 12597848 | 5 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 125978481 | 12597848 | 6 | C | MONTCAQKAST | 2 | Oral | 0 | 10 | MG | QD | |||||||||
| 125978481 | 12597848 | 7 | C | LYRICA | PREGABALIN | 1 | Oral | 0 | 200 | MG | QD | ||||||||
| 125978481 | 12597848 | 8 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 125978481 | 12597848 | 9 | C | PRAZASTATIN | 2 | Oral | 0 | 10 | MG | QD | |||||||||
| 125978481 | 12597848 | 10 | C | LANTUS | INSULIN GLARGINE | 1 | 0 | 44 | IU | QD | |||||||||
| 125978481 | 12597848 | 11 | C | COLACE | DOCUSATE SODIUM | 1 | Oral | 0 | 100 | MG | QD | ||||||||
| 125978481 | 12597848 | 12 | C | VISION SHIELD | 2 | Oral | DAILY | 0 | |||||||||||
| 125978481 | 12597848 | 13 | C | CALCIUM CITRATE-VITAMIN D | CALCIUM CITRATEVITAMIN D | 1 | Oral | 0 | 1000 | MG | QD | ||||||||
| 125978481 | 12597848 | 14 | C | LACTULOSE. | LACTULOSE | 1 | Oral | 0 | 15 | MG | Q8H |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125978481 | 12597848 | 1 | Type 2 diabetes mellitus |
| 125978481 | 12597848 | 2 | Cardiac disorder |
| 125978481 | 12597848 | 3 | Blood pressure abnormal |
| 125978481 | 12597848 | 4 | Diabetes mellitus |
| 125978481 | 12597848 | 5 | Anticoagulant therapy |
| 125978481 | 12597848 | 7 | Pain |
| 125978481 | 12597848 | 10 | Diabetes mellitus |
| 125978481 | 12597848 | 11 | Gastrointestinal motility disorder |
| 125978481 | 12597848 | 12 | Eye disorder |
| 125978481 | 12597848 | 13 | Bone disorder |
| 125978481 | 12597848 | 14 | Abdominal discomfort |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125978481 | 12597848 | Cardiac murmur | |
| 125978481 | 12597848 | Cardiac valve disease | |
| 125978481 | 12597848 | Constipation | |
| 125978481 | 12597848 | Drug dose omission | |
| 125978481 | 12597848 | Pneumonia | |
| 125978481 | 12597848 | Proteinuria |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125978481 | 12597848 | 1 | 201603 | 0 | ||
| 125978481 | 12597848 | 2 | 20160628 | 0 |